2025-11-30 - Analysis Report
Here's a breakdown of Intuitive Surgical (ISRG) based on the provided data, aiming for a comprehensive analysis:

**0) Overview**

Intuitive Surgical, Inc. is a company that designs, manufactures, and markets the da Vinci surgical system and related instruments and accessories.

**1) Return Rate Comparison**

*   **ISRG Cumulative Return:** 112.79%
*   **VOO (S&P 500) Cumulative Return:** 101.92%
*   **Divergence:** 13.8
*   **Relative Divergence:** 37.7

**Analysis:** ISRG has outperformed the S&P 500 (VOO) over the analyzed period. The current divergence of 13.8 (meaning ISRG's cumulative return is 13.8 percentage points higher) places it at the 37.7th percentile of its historical divergence range, suggesting the outperformance is not at an extreme high compared to its past.

**Alpha, Beta Analysis**

| Year       | CAGR    | MDD    | Alpha  | Beta | Cap(B) |
|------------|---------|--------|--------|------|--------|
| 2015-2017  | 68.0%   | 77.6%  | 40.0%  | -0.1 | 43.6   |
| 2016-2018  | 64.0%   | 72.2%  | 49.0%  | -0.0 | 57.2   |
| 2017-2019  | 54.0%   | 72.2%  | 31.0%  | 0.2  | 70.6   |
| 2018-2020  | -6.0%   | 80.4%  | -29.0% | 0.3  | 97.8   |
| 2019-2021  | 29.0%   | 80.4%  | -18.0% | 0.6  | 128.8  |
| 2020-2022  | -23.0%  | 80.4%  | -22.0% | 1.2  | 95.1   |
| 2021-2023  | -17.0%  | 77.5%  | -18.0% | 1.7  | 120.9  |
| 2022-2024  | 36.0%   | 77.5%  | 15.0%  | 1.7  | 187.1  |
| 2023-2025  | 75.0%   | 72.7%  | 9.0%   | 0.8  | 205.6  |

**Analysis:**

*   **CAGR:** Fluctuates significantly, showing periods of strong growth and decline. The recent 2023-2025 period shows a very strong 75% CAGR.
*   **MDD:** Relatively high Maximum Drawdown (MDD) indicates significant price volatility and risk.
*   **Alpha:** ISRG's alpha has varied, even becoming negative, indicating periods where it underperformed relative to its risk.
*   **Beta:** Beta has increased significantly over time, suggesting the stock's price movement has become more correlated with the overall market.
*   **Cap(B):** Market capitalization shows general growth over the long term, with some fluctuations in recent years.

**2) Recent Stock Price Fluctuations**

*   **Current Price:** 573.48
*   **Previous Close:** 574.23
*   **Change:** -0.13
*   **5-day SMA:** 571.334
*   **20-day SMA:** 559.072
*   **60-day SMA:** 494.2633

**Analysis:** The stock price is slightly down compared to the previous close.  The 5-day SMA is above the 20-day SMA, which is above the 60-day SMA. This indicates an upward trend over the short, medium and long term.

**3) Technical Indicators**

*   **Market Risk Indicator (MRI):** 0.9 (High Investment Recommended)
*   **RSI:** 56.21 (Neutral - neither overbought nor oversold)
*   **PPO:** -0.39 (Negative, indicating a slightly bearish trend)
*   **Hybrid Signal:** Buy 100% of cash, with a monthly investment of 0.8% of the total investment (very safe).
*   **Recent Divergence Change:** +6.1 (Indicates a short-term upward trend)
*   **Expected Return:** 21.0% (Long-term expected excess return compared to S&P 500)

**Analysis:**

*   The MRI suggests a high investment recommendation, indicating the model views the stock as relatively safe.
*   The RSI indicates neutral momentum.
*   The PPO suggests the short-term moving average is slightly below the long-term moving average, indicating bearish sentiment.
*   Despite the slight dip, the hybrid signal is a strong buy.
*   The positive divergence change backs up the upward trend in the short term.
*   The high expected return suggests significant long-term growth potential.

**4) Recent News & Significant Events**

*   **Positive Headlines:** Many headlines point to a strong recent performance, earnings turnaround, and potential for further growth (e.g., "ISRG Stock Gains More than 28% in a Month," "Intuitive Surgical Stock Is Up 31% Since October Lows").  The Forbes article even mentions a $700 target.
*   **Analyst Activity:** News mentions heavy investor interest.
*   **Potential Negative Signal:**  Curet, an Intuitive Surgical EVP, sold $58,800 in ISRG stock, which could be interpreted negatively, though it's a relatively small amount.

**4-2) Analyst Opinions**

*   **Consensus:** Buy (Mean = 2.00)
*   **Target Price:** Average target of $592.96, with a high of $700.00.

**Analysis:** Analyst sentiment is positive with a "Buy" consensus and a target price above the current market price, suggesting further upside potential. The high target price of $700 aligns with some of the positive news headlines.

**5) Recent Earnings Analysis**

| Date       | EPS  | Revenue   |
|------------|------|-----------|
| 2025-10-22 | 1.98 | 2.51 B$   |
| 2025-07-23 | 1.84 | 2.44 B$   |
| 2025-04-23 | 1.95 | 2.25 B$   |
| 2024-10-18 | 1.59 | 2.04 B$   |
| 2025-10-22 | 1.59 | 2.04 B$   |

**Analysis:**

*   Earnings per share (EPS) and revenue have generally been increasing over the past year, indicating strong financial performance.

**6) Financial Information**

**Revenue and Profitability:**

| Quarter    | Revenue   | Profit Margin |
|------------|-----------|---------------|
| 2025-09-30 | $2.51B    | 66.36%        |
| 2025-06-30 | $2.44B    | 66.31%        |
| 2025-03-31 | $2.25B    | 64.69%        |
| 2024-12-31 | $2.41B    | 68.04%        |
| 2024-09-30 | $2.04B    | 67.41%        |

**Capital and Profitability:**

| Quarter    | Equity    | ROE     |
|------------|-----------|---------|
| 2025-09-30 | $16.93B   | 4.16%   |
| 2025-06-30 | $17.85B   | 3.69%   |
| 2025-03-31 | $17.11B   | 4.08%   |
| 2024-12-31 | $16.43B   | 4.17%   |
| 2024-09-30 | $15.58B   | 3.63%   |

**Analysis:**

*   **Revenue:**  Revenue shows a strong upward trend.
*   **Profit Margin:** Consistently high profit margins, indicating a strong competitive advantage.
*   **Equity:**  Equity is relatively stable with some fluctuations.
*   **ROE:** Return on Equity (ROE) fluctuates, but remains within a reasonable range, indicating efficient use of shareholder equity to generate profits.

**7) Comprehensive Analysis**

Intuitive Surgical (ISRG) presents a mixed but generally positive picture:

*   **Strengths:**
    *   **Outperformance:** ISRG has historically outperformed the S&P 500.
    *   **Strong Financials:**  Robust revenue growth, high profit margins, and increasing EPS demonstrate strong financial health.
    *   **Positive Sentiment:** Analyst consensus is "Buy," with a target price suggesting upside potential. Recent news is largely positive, highlighting strong performance and potential growth.
    *   **Technical Indicators:** The MRI suggests a good investment, although some of the other technical indicators show a neutral or slightly bearish outlook.
    *   **Dominant Position:** As a leader in robotic surgery, Intuitive Surgical benefits from a strong market position and high barriers to entry.
*   **Weaknesses:**
    *   **Volatility:** The high MDD indicates significant price volatility.
    *   **Beta:** The rising beta indicates the stock is becoming more correlated to overall market risk, reducing its diversification benefit.
    *   **Mixed Technical Signals:** While the MRI is positive, the PPO is negative, and the RSI is neutral.
    *   **Executive Stock Sale:** The sale of stock by an EVP could be seen as a potential red flag, although it was a relatively small sale.
*   **Overall:**
    *   ISRG appears to be a fundamentally strong company with positive growth prospects, supported by analyst sentiment and recent performance. However, investors should be aware of the inherent volatility and market risk associated with the stock.
    *   The "Buy" recommendation based on the hybrid signal is a good starting point. Investors should carefully consider their risk tolerance and investment horizon.


**Disclaimer:** This report is for informational purposes only and does not constitute financial advice. Investment involves risk.